Immutep Raises A$6.85M Through Institutional Placement

Read ASX Announcement Here • A$6.85m raised through share institutional placement to drive immuno-oncology development programs • Placement of new ordinary shares to leading Australian healthcare institutional investors Platinum Asset Management and Australian Ethical Investment, U.S. healthcare institutional…

Read More

Immutep Enters Into Clinical Trial Collaboration and Supply Agreement with MSD

Read ASX Announcement Here Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”) has announced that it has entered into a clinical trial collaboration and supply agreement with Merck & Co., Inc., Kenilworth, NJ, USA (known as…

Read More

Event Summary – Clinical Trials in Victoria: Building global competitive advantage

Summary by Millie Dwyer, Student Intern This BioMelbourne Network BioBreakfast event hosted at St Vincent’s launched the Victorian Clinical Trials Gateway and discussed Victoria’s clinical trial landscape. The event explored Victoria’s strengths and weaknesses in this field, inspiring…

Read More


News & opinion

Member Directory